REFERENCES
- Pui C, Williams J, Wang W. Evans syndrome in childhood. J Paediatr 1980; 97: 754–758
- Lammers A, Hislop A A, Flynn Y, Haworth S G. Epoprostenol treatment in children with severe pulmonary hypertension. Heart 2006, Oct 25. (Epub ahead of print)
- Maiya S, Hislop A A, Flynn Y, Haworth S G. Response to bosentan in children with pulmonary hypertension. Heart 2006; 92: 664–670
- Berger S, Konduri G G. Pulmonary hypertension in children: the twenty-first century. Pediatr Clin North Am 2006; 53: 961–987
- Straus S E, Sneller M, Lenardo M, Puck J, Strober W. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med 1999; 13: 591–601
- Vashinsky E. Pulmonary hypertension in sickle cell disease. N Engl J Med 2004; 350: 857–859
- Gladwin M, Sachdev V, Jison J, et al. Pulmonary hypertension as a risk factor for death in sickle cell disease
- Simonneau G, Nazzareno G, Lewis R J, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: 5S–12S
- Barst R, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 40S–47S